These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

111 related items for PubMed ID: 6470639

  • 1. Duration of vaccine-induced poliomyelitis immunity.
    Mayer TR.
    J Fam Pract; 1984 Sep; 19(3):385-6, 388. PubMed ID: 6470639
    [No Abstract] [Full Text] [Related]

  • 2. [On the problem of revaccination against poliomyelitis. Results of a reinfection experiment using the poliovirus type 1, strain "LSc, 2ab (Sabin)". 4 and half years following original vaccination].
    Kuwert E, Posch J, Lagarie G.
    Med Klin; 1968 May 03; 63(18):701-7. PubMed ID: 4305218
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. [The perspective of global eradication of poliomyelitis].
    Knolle H, Egli A, Candrian U.
    Gesundheitswesen; 2004 Jan 03; 66(1):1-6. PubMed ID: 14767784
    [Abstract] [Full Text] [Related]

  • 5. Updated recommendations of the Advisory Committee on Immunization Practices (ACIP) regarding routine poliovirus vaccination.
    Centers for Disease Control and Prevention (CDC).
    MMWR Morb Mortal Wkly Rep; 2009 Aug 07; 58(30):829-30. PubMed ID: 19661857
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Anomalous observations on IPV and OPV vaccination.
    John TJ.
    Dev Biol (Basel); 2001 Aug 07; 105():197-208. PubMed ID: 11763328
    [Abstract] [Full Text] [Related]

  • 8. Letter: Antibodies to poliovirus.
    MacLeod DR.
    Can Med Assoc J; 1976 May 08; 114(9):754-6. PubMed ID: 1268785
    [No Abstract] [Full Text] [Related]

  • 9. [The immunity in the population of the Saarland after poliomyelitis oral vaccination. 1].
    Esser I.
    Offentl Gesundheitswes; 1970 Dec 08; 32(12):655-60. PubMed ID: 4250371
    [No Abstract] [Full Text] [Related]

  • 10. Need for polio boosters after age two years.
    Rennels MB.
    Vaccine; 2009 Jan 07; 27(2):179-80. PubMed ID: 19007837
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Assessment of humoral immunity to poliomyelitis, tetanus, hepatitis B, measles, rubella, and mumps in children after chemotherapy.
    Fioredda F, Giacchino M, Castagnola E.
    Cancer; 2005 Apr 15; 103(8):1758-9; author reply 1760. PubMed ID: 15717298
    [No Abstract] [Full Text] [Related]

  • 14. Assessment of humoral immunity to poliomyelitis, tetanus, hepatitis B, measles, rubella, and mumps in children after chemotherapy.
    Laws HJ, Calaminus G, Göbel U.
    Cancer; 2005 Apr 15; 103(8):1759; author reply 1760. PubMed ID: 15717299
    [No Abstract] [Full Text] [Related]

  • 15. Poliovirus-specific memory immunity in seronegative elderly people does not protect against virus excretion.
    Abbink F, Buisman AM, Doornbos G, Woldman J, Kimman TG, Conyn-van Spaendonck MA.
    J Infect Dis; 2005 Mar 15; 191(6):990-9. PubMed ID: 15717277
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. [Vaccination schedule for children].
    Stickl H.
    Fortschr Med; 1982 Oct 14; 100(38):1761-3. PubMed ID: 7141375
    [No Abstract] [Full Text] [Related]

  • 20. Impact of the sequential IPV/OPV schedule on vaccination coverage levels--United States, 1997.
    Centers for Disease Control and Prevention (CDC).
    MMWR Morb Mortal Wkly Rep; 1998 Dec 04; 47(47):1017-9. PubMed ID: 9853937
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.